+499.5%
MRNA vs RY
+46.1%
+453.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | RY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.7% | -1.5% | -2.8% |
| 7D | +5.5% | +3.1% | +2.4% | +8.3% |
| 30D | +158.7% | -0.3% | +159.1% | +155.6% |
| 3M | +182.1% | +8.7% | +173.5% | +154.5% |
| 6M | +151.8% | +28.5% | +123.3% | +88.9% |
| YTD | +393.6% | +25.1% | +368.4% | +277.3% |
| 1Y | +499.5% | +46.3% | +453.2% | +243.2% |
| All | +499.5% | +46.1% | +453.4% | +243.2% |
Cumulative growth
Daily Returns
Daily percentage return beside RY.
Daily Out/Under-Performance
Portfolio return minus RY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × RY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded RY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling